Shares of Aurobindo Pharma gained 2.21% to trade at Rs 1,102.00 in Thursday's early session. The stock is performing positively in today's session. The stock is among top gainers on Nifty Midcap 150 index.
Aurobindo Pharma is included as one of the stocks in the Nifty Midcap 150 index.
Financial Performance:
Aurobindo Pharma's financial performance shows consistent growth in key areas. Here’s an overview:
Consolidated Quarterly Performance:
The consolidated quarterly financial results indicate a strong revenue and profit trend.
| Heading | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Revenue | Rs 7,567.02 Crore | Rs 7,796.07 Crore | Rs 7,978.52 Crore | Rs 8,382.12 Crore | Rs 7,868.14 Crore |
| Net Profit | Rs 919.61 Crore | Rs 816.65 Crore | Rs 843.98 Crore | Rs 935.02 Crore | Rs 822.28 Crore |
| EPS | 15.69 | 14.00 | 14.56 | 15.56 | 14.20 |
Consolidated Yearly Performance:
The consolidated yearly financial results demonstrate a steady increase in revenue and net profit.
| Heading | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | Rs 24,774.62 Crore | Rs 23,455.49 Crore | Rs 24,855.38 Crore | Rs 29,001.87 Crore | Rs 31,723.73 Crore |
| Net Profit | Rs 5,389.18 Crore | Rs 2,678.36 Crore | Rs 1,939.32 Crore | Rs 3,186.13 Crore | Rs 3,515.26 Crore |
| EPS | 91.05 | 45.19 | 32.90 | 54.16 | 59.81 |
| BVPS | 374.28 | 419.42 | 458.30 | 509.49 | 562.21 |
| ROE | 24.32 | 10.77 | 7.18 | 10.63 | 10.67 |
| Debt to Equity | 0.23 | 0.10 | 0.18 | 0.21 | 0.24 |
Cash Flow:
The cash flow statement provides insights into the company's liquidity and financial health.
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Operating Activities | Rs 3,328 Crore | Rs 5,016 Crore | Rs 2,386 Crore | Rs 2,434 Crore | Rs 3,924 Crore |
| Investing Activities | Rs 598 Crore | Rs -3,211 Crore | Rs -3,977 Crore | Rs -4,255 Crore | Rs -1,875 Crore |
| Financing Activities | Rs -1,364 Crore | Rs -2,969 Crore | Rs 1,814 Crore | Rs 800 Crore | Rs 119 Crore |
| Others | Rs 20 Crore | Rs -3 Crore | Rs 6 Crore | Rs 14 Crore | Rs 9 Crore |
| Net Cash Flow | Rs 2,583 Crore | Rs -1,167 Crore | Rs 229 Crore | Rs -1,006 Crore | Rs 2,178 Crore |
The balance sheet details the company's assets, liabilities, and equity.
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Share Capital | Rs 58 Crore | Rs 58 Crore | Rs 58 Crore | Rs 58 Crore | Rs 58 Crore |
| Reserves & Surplus | Rs 21,871 Crore | Rs 24,517 Crore | Rs 26,781 Crore | Rs 29,784 Crore | Rs 32,595 Crore |
| Current Liabilities | Rs 10,665 Crore | Rs 8,155 Crore | Rs 11,493 Crore | Rs 12,199 Crore | Rs 14,682 Crore |
| Other Liabilities | Rs 1,258 Crore | Rs 1,189 Crore | Rs 1,556 Crore | Rs 3,029 Crore | Rs 2,449 Crore |
| Total Liabilities | Rs 33,853 Crore | Rs 33,921 Crore | Rs 39,889 Crore | Rs 45,071 Crore | Rs 49,784 Crore |
| Fixed Assets | Rs 12,006 Crore | Rs 13,803 Crore | Rs 15,817 Crore | Rs 17,766 Crore | Rs 19,076 Crore |
| Current Assets | Rs 19,823 Crore | Rs 18,122 Crore | Rs 21,545 Crore | Rs 24,205 Crore | Rs 27,162 Crore |
| Other Assets | Rs 2,024 Crore | Rs 1,995 Crore | Rs 2,526 Crore | Rs 3,099 Crore | Rs 3,546 Crore |
| Total Assets | Rs 33,853 Crore | Rs 33,921 Crore | Rs 39,889 Crore | Rs 45,071 Crore | Rs 49,784 Crore |
| Contingent Liabilities | Rs 1,083 Crore | Rs 1,145 Crore | Rs 1,813 Crore | Rs 3,323 Crore | Rs 0 Crore |
Key financial ratios provide insights into the company's performance and efficiency.
| Ratio | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Basic EPS (Rs.) | 91.05 | 45.19 | 32.90 | 54.16 | 59.81 |
| Diluted EPS (Rs.) | 91.05 | 45.19 | 32.90 | 54.16 | 59.81 |
| Book Value / Share (Rs.) | 374.28 | 419.42 | 458.30 | 509.49 | 562.21 |
| Dividend/Share (Rs.) | 4.00 | 9.00 | 3.00 | 4.50 | 0.00 |
| Face Value | 1 | 1 | 1 | 1 | 1 |
| Gross Profit Margin (%) | 23.06 | 20.06 | 16.13 | 22.06 | 22.71 |
| Operating Margin (%) | 18.80 | 15.26 | 11.12 | 16.82 | 17.51 |
| Net Profit Margin (%) | 21.75 | 11.41 | 7.80 | 10.98 | 11.08 |
| Return on Equity (%) | 24.32 | 10.77 | 7.18 | 10.63 | 10.67 |
| ROCE (%) | 20.09 | 13.89 | 9.73 | 14.84 | 15.82 |
| Return On Assets (%) | 15.75 | 7.80 | 4.83 | 7.03 | 7.00 |
| Current Ratio (X) | 1.86 | 2.22 | 1.87 | 1.98 | 1.85 |
| Quick Ratio (X) | 1.01 | 1.30 | 1.13 | 1.18 | 1.13 |
| Debt to Equity (x) | 0.23 | 0.10 | 0.18 | 0.21 | 0.24 |
| Interest Coverage Ratios (X) | 76.71 | 96.77 | 28.54 | 22.09 | 15.76 |
| Asset Turnover Ratio (%) | 0.79 | 0.69 | 0.67 | 0.68 | 0.67 |
| Inventory Turnover Ratio (X) | 0.99 | 0.89 | 1.20 | 1.18 | 1.06 |
| 3 Yr CAGR Sales (%) | 22.67 | 9.50 | 3.73 | 8.20 | 16.30 |
| 3 Yr CAGR Net Profit (%) | 49.24 | 6.49 | -17.43 | -23.11 | 14.56 |
| P/E (x) | 9.68 | 14.79 | 15.75 | 20.10 | 19.40 |
| P/B (x) | 2.36 | 1.59 | 1.13 | 2.14 | 2.06 |
| EV/EBITDA (x) | 8.95 | 7.94 | 7.27 | 9.98 | 9.31 |
| P/S (x) | 2.08 | 1.67 | 1.22 | 2.20 | 2.12 |
Aurobindo Pharma has been actively involved in several corporate actions.
Aurobindo Pharma had earlier splits and bonus issues. The company had a stock split on February 10, 2011 where old FV was 5 and new FV was 1.
Aurobindo Pharma is moved by 2.21.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
